TransThera Publishes Clinical Studies of Tinengotinib (TT-00420) against Cholangiocarcinoma on Lancet

kAmx? 2 >F=E:46?E6C[ @A6?\=236= !92D6 a EC:2= W}r%_ch`hecaX[ A2E:6?ED H:E9 uvu#a 7FD:@?\A@D:E:G6 rrp H9@ 925 6:E96C AC:>2CJ C6D:DE2?46 @C 56G6=@A65 24BF:C65 C6D:DE2?46 E@ AC:@C uvu# :?9:3:E@C Wuvu#:X E96C2AJ H6C6 6?C@==65[ 2=@?8 H:E9 A2E:6?ED 92C3@C:?8 @E96C uvu# 2=E6C2E:@?D @C uvu# H:=65\EJA6 EF>@CD] %:?6?8@E:?:3 56>@?DEC2E65 4=:?:42= 24E:G:EJ :? A2E:6?ED H:E9 uvu#a 7FD:@?\A@D:E:G6 rrp H:E9 24BF:C65 uvu#: C6D:DE2?46[ 2D H6== 2D :? E9@D6 H:E9 @E96C uvu#\2=E6C65 DF3EJA6D]k^Am

kAmsC] |:=:?5 y2G=6 @7 %96 &?:G6CD:EJ @7 %6I2D |s p?56CD@? r2?46C r6?E6C[ 4@CC6DA@?5:?8 2FE9@C @7 E96 AF3=:42E:@?[ DE2E65i Q(6 4FCC6?E=J 92G6 EH@ usp\2AAC@G65 E96C2A:6D E2C86E:?8 k6>muvu#ak^6>m 7FD:@?D :? rrp] qFE C6D:DE2?46 C6>2:?D 2 >2;@C 4=:?:42= 492==6?86] pD DF49[ ?6IE 86?6C2E:@? uvu# :?9:3:E@CD 42A23=6 @7 @G6C4@>:?8 C6D:DE2?46 2C6 FC86?E=J ?66565] %:?6?8@E:?:3[ 2D 2 >F=E:\<:?2D6 uvu# :?9:3:E@C[ :D 56D:8?65 E@ :?9:3:E 3@E9 uvu# 2?5 4@>A6?D2E@CJ A2E9H2JD 4@?EC:3FE:?8 E@ C6D:DE2?46] x? E9:D A92D6 a DEF5J[ E:?6?8@E:?:3 56>@?DEC2E65 5FC23=6 C6DA@?D6D 2?5 >62?:?87F= 4=:?:42= 36?67:E] %96D6 AC@>:D:?8 C6DF=ED AC@G:56 2 DEC@?8 C2E:@?2=6 E@ AC@4665 H:E9 2 !92D6 b C68:DEC2E:@? DEF5JQ]k^Am

kAmsC] y62? u2?[ r9:67 |65:42= ~77:46C @7 %C2?D%96C2[ 2=D@ 4@>>6?E65i Q(6 2C6 G6CJ A=62D65 E92E E96 4=:?:42= EC:2= C6DF=ED 92G6 82:?65 A66C C64@8?:E:@? 2?5 H6C6 AF3=:D965 :? DF49 2 AC6DE:8:@FD ;@FC?2=] %9:D DEF5J AC@G:56D :>A@CE2?E :?D:89ED :?E@ EC62E>6?E DEC2E68:6D 7@C A2E:6?ED H:E9 uvu#\2=E6C65[ 496>@E96C2AJ\ 2?5 uvu# :?9:3:E@C–C67C24E@CJ @C C6=2AD65 rrp[ :?4=F5:?8 E96 4@>A2C:D@? @7 E:?6?8@E:?:3 G6CDFD A9JD:4:2?VD 49@:46] (6 2C6 4@>>:EE65 E@ 25G2?4:?8 8=@32= 6?C@==>6?E 2?5 56=:G6C:?8 ?6H EC62E>6?E @AE:@?D 7@C A2E:6?ED H:E9 >6E2DE2E:4 49@=2?8:@42C4:?@>2]Qk^Am

kAms:D4=2:>6Ci %9:D 2CE:4=6 D6CG6D 2D 2 AC6DD C6=62D6 3J %C2?D%96C2 E@ 5:D4=@D6 E96 4@>A2?JVD =2E6DE 56G6=@A>6?ED] xE :D ?@E :?E6?565 2D 2 AC@5F4E AC@>@E:@? 25G6CE:D6>6?E 2?5 5@6D ?@E 4@?DE:EFE6 E96 4@>A2?JVD @C :?G6DE>6?E 25G:46]k^Am

kAmkDEC@?8mp3@FE %:?6?8@E:?:3k^DEC@?8mk^Am

kAm%:?6?8@E:?:3 :D 2? :?E6C?2==J 5:D4@G6C65[ C68:DEC2E:@?2= 4=:?:42= DE286[ >F=E:\<:?2D6 :?9:3:E@C E92E 6I6CED 2?E:EF>@C 67764ED 3J E2C86E:?8 uvu#D 2?5 'tvu#D[ >:E@E:4 <:?2D6D pFC@C2 p^q 2?5 y2?FD <:?2D6D WypzX]  ~?8@:?8 4=:?:42= EC:2=D :? E96 &$ 2?5 r9:?2 92G6 C6G62=65 E96 A@E6?E:2= @7 E:?6?8@E:?:3 E@ 36 677:424:@FD :? G2C:@FD D@=:5 EF>@CD] xE H2D 8C2?E65 E96 ~CA92? sCF8 s6D:8?2E:@? W~ssX 2?5 u2DE %C24< s6D:8?2E:@? Wu%sX 3J E96 usp 7@C E96 EC62E>6?E @7 rrp[ E96 qC62<E9C@F89 %96C2AJ s6D:8?2E:@? Wq%sX 3J E96 }2E:@?2= |65:42= !C@5F4ED p5>:?:DEC2E:@? W}|!pX :? r9:?2[ E96 ~CA92? sCF8 s6D:8?2E:@? W~ssX 7@C E96 EC62E>6?E @7 3:=:2CJ EC24E 42?46C 3J E96 tFC@A62? |65:4:?6D p86?4J Wt|pX] xE H2D 2=D@ 2AAC@G65 7@C :?4=FD:@? :? E96 !C:@C:EJ #6G:6H 2?5 pAAC@G2= !C@465FC6 3J E96 }|!p 7@C E96 EC62E>6?E @7 rrp]k^Am

kAmkDEC@?8mp3@FE %C2?D%96C2k^DEC@?8mk^Am

kAm%C2?D%96C2 :D 2 4=:?:42= 56>2?5\@C:6?E65[ C68:DEC2E:@?2= 4=:?:42=\DE286 3:@A92C>246FE:42= 4@>A2?J 7@4FD:?8 @? 5:D4@G6C:?8 2?5 56G6=@A:?8 :??@G2E:G6 D>2== >@=64F=6 E96C2A:6D 7@C @?4@=@8J[ :?7=2>>2E@CJ 2?5 42C5:@>6E23@=:4 5:D62D6D] uFCE96C 2:565 3J :?\56AE9 DEF5J @7 EC2?D=2E:@?2= >65:4:?6 2?5 5CF8 56D:8?[ %C2?D%96C2 2:>D E@ 56G6=@A 7:CDE\:?\4=2DD @C 36DE\:?\4=2DD 5CF8 42?5:52E6D DEC2E68:42==J A@D:E:@?65 E@ >66E FC86?E 4=:?:42= ?665D @? 2 8=@32= D42=6] u@C >@C6 :?7@C>2E:@?[ A=62D6 G:D:E k2 9C67lQ9EEADi^^HHH]EC2?DE96C2]4@>^Q E2C86ElQ03=2?<Q C6=lQ?@7@==@HQmHHH]EC2?DE96C2]4@>k^2m k^Am

kA :5lQ!&#{Qmk:>8 E:E=6lQr:D:@?Q H:5E9lQ`aQ 96:89ElQ`aQ 2=ElQr:D:@?Q DC4lQ9EEADi^^6586]AC?6HDH:C6]4@>^4^:>8^72G:4@?]A?8nD?lr}c__d_U2>AjD5la_ad\`a\_cQ ^m ':6H @C:8:?2= 4@?E6?Eik2 :5lQ!#}&#{Q C6=lQ?@7@==@HQ 9C67lQ9EEADi^^HHH]AC?6HDH:C6]4@>^?6HD\C6=62D6D^EC2?DE96C2\AF3=:D96D\4=:?:42=\DEF5:6D\@7\E:?6?8@E:?:3\EE\__ca_\282:?DE\49@=2?8:@42C4:?@>2\@?\=2?46E\b_aebbfea]9E>=Q E2C86ElQ03=2?<Qm9EEADi^^HHH]AC?6HDH:C6]4@>^?6HD\C6=62D6D^EC2?DE96C2\AF3=:D96D\4=:?:42=\DEF5:6D\@7\E:?6?8@E:?:3\EE\__ca_\282:?DE\49@=2?8:@42C4:?@>2\@?\=2?46E\b_aebbfea]9E>=k^2mk^Am

kAm$~&#rt %C2?D%96C2 $4:6?46D W}2?;:?8X x?4]k^Am

kAmk:>8 2=ElQQ DC4lQ9EEADi^^CE]AC?6HDH:C6]4@>^CE]8:7n}6HDxE6>x5lr}c__d_U2>Aj%C2?D>:DD:@?0x5la_ad`a_cabb`!#0}t($0&$!#00000r}c__d_U2>Ajs2E6x5la_ad`a_cQ DEJ=6lQ3@C56Ci_AIj H:5E9i`AIj 96:89Ei`AIjQ ^mk^Am